Bezatol - Slow Release


Indications and Reactions:

Role Indications Reactions
Secondary
Diabetes Mellitus 24.5%
Anxiety Disorder 14.3%
Hypertension 14.3%
Pain 12.2%
Insomnia 8.2%
Bronchopulmonary Aspergillosis 4.1%
Cardiovascular Insufficiency 4.1%
Constipation 4.1%
Depression 4.1%
Gastritis 4.1%
Sinusitis Aspergillus 4.1%
Hyperlipidaemia 2.0%
Malaise 23.5%
Hypothermia 17.6%
Blood Creatine Phosphokinase Increased 11.8%
Rhabdomyolysis 11.8%
Atrioventricular Block 5.9%
Blood Sodium Decreased 5.9%
Hyperkalaemia 5.9%
Somnolence 5.9%
Suicide Attempt 5.9%
Upper Respiratory Tract Inflammation 5.9%
Concomitant
Hypertension 34.5%
Hyperlipidaemia 9.4%
Prophylaxis 8.6%
Angina Pectoris 5.6%
Hyperuricaemia 4.3%
Cancer Pain 3.9%
Chronic Myeloid Leukaemia 3.9%
Metastatic Renal Cell Carcinoma 3.6%
Diabetes Mellitus 3.4%
Cardiac Failure Chronic 2.8%
Pruritus 2.8%
Insomnia 2.4%
Gastritis 2.1%
Metastases To Bone 2.1%
Multiple Drug Overdose Intentional 1.9%
Reflux Oesophagitis 1.9%
Lung Adenocarcinoma Stage Iv 1.7%
Myasthenia Gravis 1.7%
Renal Transplant 1.7%
Atrial Fibrillation 1.5%
Prothrombin Time Ratio Increased 7.5%
Tooth Extraction 7.5%
Hepatic Function Abnormal 6.0%
Hypotension 6.0%
Oedema Peripheral 6.0%
Rhabdomyolysis 6.0%
Sepsis 6.0%
White Blood Cell Count Decreased 6.0%
Hypertension 4.5%
Hypertriglyceridaemia 4.5%
Hypoaesthesia Facial 4.5%
Myalgia 4.5%
Pancreatitis 4.5%
Suicide Attempt 4.5%
Visual Impairment 4.5%
Vomiting 4.5%
Wound Infection Staphylococcal 4.5%
Anaphylactic Shock 3.0%
Blood Amylase Increased 3.0%
Blood Pressure Diastolic Increased 3.0%

Drug Data